BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33608450)

  • 1. Molecular Determinants of Medulloblastoma Metastasis and Leptomeningeal Dissemination.
    Li M; Deng Y; Zhang W
    Mol Cancer Res; 2021 May; 19(5):743-752. PubMed ID: 33608450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma.
    Jenkins NC; Kalra RR; Dubuc A; Sivakumar W; Pedone CA; Wu X; Taylor MD; Fults DW
    Acta Neuropathol Commun; 2014 Jul; 2():85. PubMed ID: 25059231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas.
    Grausam KB; Dooyema SDR; Bihannic L; Premathilake H; Morrissy AS; Forget A; Schaefer AM; Gundelach JH; Macura S; Maher DM; Wang X; Heglin AH; Ge X; Zeng E; Puget S; Chandrasekar I; Surendran K; Bram RJ; Schüller U; Talyor MD; Ayrault O; Zhao H
    Cancer Res; 2017 Jul; 77(14):3766-3777. PubMed ID: 28490517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential patterns of metastatic dissemination across medulloblastoma subgroups.
    Zapotocky M; Mata-Mbemba D; Sumerauer D; Liby P; Lassaletta A; Zamecnik J; Krskova L; Kyncl M; Stary J; Laughlin S; Arnoldo A; Hawkins C; Tabori U; Taylor MD; Bouffet E; Raybaud C; Ramaswamy V
    J Neurosurg Pediatr; 2018 Feb; 21(2):145-152. PubMed ID: 29219788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular biology of medulloblastoma metastasis.
    Van Ommeren R; Garzia L; Holgado BL; Ramaswamy V; Taylor MD
    Brain Pathol; 2020 May; 30(3):691-702. PubMed ID: 31883407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
    Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
    Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics.
    Yang H; Li M; Deng Y; Wen H; Luo M; Zhang W
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23233. PubMed ID: 38607297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47.
    Yang SY; Choi SA; Lee JY; Park AK; Wang KC; Phi JH; Koh EJ; Park WY; Park SH; Hwang DW; Jung HW; Kim SK
    Oncotarget; 2015 Dec; 6(41):43712-30. PubMed ID: 26506238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants.
    Buss MC; Remke M; Lee J; Gandhi K; Schniederjan MJ; Kool M; Northcott PA; Pfister SM; Taylor MD; Castellino RC
    Oncogene; 2015 Feb; 34(9):1126-40. PubMed ID: 24632620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.
    Fults DW; Taylor MD; Garzia L
    J Neurosurg Pediatr; 2019 Feb; ():1-9. PubMed ID: 30771762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice.
    McCall TD; Pedone CA; Fults DW
    Cancer Res; 2007 Jun; 67(11):5179-85. PubMed ID: 17545597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.
    Bai AH; Milde T; Remke M; Rolli CG; Hielscher T; Cho YJ; Kool M; Northcott PA; Jugold M; Bazhin AV; Eichmüller SB; Kulozik AE; Pscherer A; Benner A; Taylor MD; Pomeroy SL; Kemkemer R; Witt O; Korshunov A; Lichter P; Pfister SM
    Acta Neuropathol; 2012 Apr; 123(4):529-38. PubMed ID: 22134538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
    Ferrucci V; de Antonellis P; Pennino FP; Asadzadeh F; Virgilio A; Montanaro D; Galeone A; Boffa I; Pisano I; Scognamiglio I; Navas L; Diana D; Pedone E; Gargiulo S; Gramanzini M; Brunetti A; Danielson L; Carotenuto M; Liguori L; Verrico A; Quaglietta L; Errico ME; Del Monaco V; D'Argenio V; Tirone F; Mastronuzzi A; Donofrio V; Giangaspero F; Picard D; Remke M; Garzia L; Daniels C; Delattre O; Swartling FJ; Weiss WA; Salvatore F; Fattorusso R; Chesler L; Taylor MD; Cinalli G; Zollo M
    Brain; 2018 May; 141(5):1300-1319. PubMed ID: 29490009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.
    MacDonald TJ; Brown KM; LaFleur B; Peterson K; Lawlor C; Chen Y; Packer RJ; Cogen P; Stephan DA
    Nat Genet; 2001 Oct; 29(2):143-52. PubMed ID: 11544480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Drivers in Pediatric Medulloblastoma.
    Roussel MF; Stripay JL
    Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
    Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
    J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
    Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
    Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.
    Garzia L; Kijima N; Morrissy AS; De Antonellis P; Guerreiro-Stucklin A; Holgado BL; Wu X; Wang X; Parsons M; Zayne K; Manno A; Kuzan-Fischer C; Nor C; Donovan LK; Liu J; Qin L; Garancher A; Liu KW; Mansouri S; Luu B; Thompson YY; Ramaswamy V; Peacock J; Farooq H; Skowron P; Shih DJH; Li A; Ensan S; Robbins CS; Cybulsky M; Mitra S; Ma Y; Moore R; Mungall A; Cho YJ; Weiss WA; Chan JA; Hawkins CE; Massimino M; Jabado N; Zapotocky M; Sumerauer D; Bouffet E; Dirks P; Tabori U; Sorensen PHB; Brastianos PK; Aldape K; Jones SJM; Marra MA; Woodgett JR; Wechsler-Reya RJ; Fults DW; Taylor MD
    Cell; 2018 Feb; 172(5):1050-1062.e14. PubMed ID: 29474906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.